OverviewChartNewsTraderScreen

Conformis/  US20717E2000  /

NASDAQ
01/09/2023  21:57:42 Chg. - Volume Bid01:50:00 Ask01:50:00 High Low
2.2600USD - 7,081
Turnover: 13,841.5370		 2.2400Bid Size: - 2.2700Ask Size: - 2.2700 2.2500
GlobeNewswire 05/09/2023 restor3d Completes Acquisition of Conformis
GlobeNewswire 23/08/2023 Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the...
GlobeNewswire 21/08/2023 Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger ...
GlobeNewswire 14/03/2022 Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire 11/03/2022 Gary Fischetti nominated to join Conformis’ Board of Directors
GlobeNewswire 02/03/2022 Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results
GlobeNewswire 02/03/2022 Conformis Suspends All Distribution Operations and Business Development in Russia
GlobeNewswire 28/02/2022 New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over ...
GlobeNewswire 24/02/2022 Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopa...
GlobeNewswire 18/02/2022 Conformis, Inc. to Participate in Upcoming Investor Conferences
GlobeNewswire 20/01/2022 Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
GlobeNewswire 04/01/2022 Conformis, Inc. to Provide Business Update and Initial Expectations for 2022 on January 6, 2022
GlobeNewswire 23/12/2021 Conformis, Inc. Announces Departure of Chief Legal Officer, Corporate Secretary
GlobeNewswire 08/11/2021 Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant R...
GlobeNewswire 03/11/2021 Conformis Reports Third Quarter 2021 Financial Results
GlobeNewswire 04/10/2021 Conformis, Inc. to Release Third Quarter 2021 Financial Results on November 3, 2021
GlobeNewswire 29/09/2021 Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
GlobeNewswire 20/09/2021 Conformis, Inc. Provides Business Update
GlobeNewswire 07/09/2021 Conformis, Inc. to Participate in Upcoming Investor Conferences
GlobeNewswire 18/08/2021 Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement Sys...
GlobeNewswire 04/08/2021 Conformis Reports Second Quarter 2021 Financial Results
GlobeNewswire 14/07/2021 Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
GlobeNewswire 07/07/2021 Conformis, Inc. Announces Settlement of Wright Medical Patent Litigation
GlobeNewswire 01/07/2021 Conformis, Inc. to Release Second Quarter 2021 Financial Results on August 4, 2021
GlobeNewswire 23/06/2021 Conformis, Inc. Announces Exclusive Distribution Agreement in China